George J. Bosl

Sloan-Kettering Institute For Cancer Res

$8,065,724

Attributed

$8,065,724

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY2005–07

$2M$1.5M$1M$500K$0

'05

'06

'07

Funding mix

By agency

NIH$14,253,114 · 7

By mechanism

P01$6,753,295 · 2

T32$3,781,279 · 1

P20$3,133,642 · 1

U10$333,342 · 1

R01$251,556 · 2

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Institute For Cancer Res

Same institution · by research overlap

Joseph Rocco Bertino$26,398,552
Lorraine J Gudas$39,938,263
David A Scheinberg$21,198,583
Arti Hurria$7,678,132
Kim Kramer$2,359,989

Others in their field

Top investigators on “Neoplasm /Cancer Chemotherapy”

Charles A Coltman · Southwest Oncology Group$171,655,324
Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
Philip J Disaia · University Of California Irvine$41,530,194
Walter J Curran · Thomas Jefferson University$37,520,030
Samuel A Wells · Duke University$32,148,803
Gregory H Reaman · National Childhood Cancer Foundation$19,436,422

Research focus

Neoplasm /Cancer ChemotherapyHuman Therapy EvaluationNeoplasm /CancerAntineoplasticsClinical ResearchNeoplasm /Cancer GeneticsHuman SubjectProstate NeoplasmsAgingBreast NeoplasmsNeoplasm /Cancer VaccineGerm Cell NeoplasmsCis Platinum CompoundBone Marrow TransplantationBladder NeoplasmNeoplasm /Cancer ImmunotherapyGeriatricsNeoplasm /Cancer Radiation TherapyPatient Oriented ResearchCyclophosphamideHead /Neck NeoplasmClinical TrialsCombination Cancer TherapyDrug Resistance